Pinnacle Associates’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-53,775
Closed -$476K 841
2023
Q1
$476K Hold
53,775
0.01% 532
2022
Q4
$490K Buy
53,775
+100
+0.2% +$912 0.01% 505
2022
Q3
$433K Buy
53,675
+36,300
+209% +$293K 0.01% 521
2022
Q2
$131K Sell
17,375
-9,855
-36% -$74.3K ﹤0.01% 724
2022
Q1
$256K Buy
+27,230
New +$256K ﹤0.01% 704
2020
Q4
Sell
-11,690
Closed -$105K 715
2020
Q3
$105K Sell
11,690
-9,951
-46% -$89.4K ﹤0.01% 659
2020
Q2
$267K Buy
+21,641
New +$267K 0.01% 578
2019
Q2
Sell
-13,770
Closed -$216K 731
2019
Q1
$216K Sell
13,770
-509
-4% -$7.98K ﹤0.01% 661
2018
Q4
$220K Sell
14,279
-2,583
-15% -$39.8K 0.01% 631
2018
Q3
$363K Sell
16,862
-6,000
-26% -$129K 0.01% 571
2018
Q2
$556K Buy
22,862
+2,272
+11% +$55.3K 0.01% 506
2018
Q1
$352K Sell
20,590
-36,711
-64% -$628K 0.01% 555
2017
Q4
$1.09M Sell
57,301
-50,032
-47% -$948K 0.02% 392
2017
Q3
$1.89M Sell
107,333
-51,247
-32% -$902K 0.03% 315
2017
Q2
$5.27M Buy
158,580
+17,241
+12% +$573K 0.1% 193
2017
Q1
$4.54M Buy
141,339
+27,043
+24% +$868K 0.09% 215
2016
Q4
$4.14M Sell
114,296
-95,138
-45% -$3.45M 0.08% 216
2016
Q3
$9.64M Sell
209,434
-51,166
-20% -$2.35M 0.19% 130
2016
Q2
$13.1M Buy
260,600
+39,509
+18% +$1.98M 0.28% 97
2016
Q1
$11.8M Buy
221,091
+48,449
+28% +$2.59M 0.25% 109
2015
Q4
$11.3M Buy
172,642
+12,175
+8% +$799K 0.24% 111
2015
Q3
$9.06M Buy
160,467
+1,428
+0.9% +$80.6K 0.2% 122
2015
Q2
$9.4M Buy
159,039
+17,491
+12% +$1.03M 0.17% 128
2015
Q1
$8.82M Buy
141,548
+74,251
+110% +$4.63M 0.16% 138
2014
Q4
$3.87M Sell
67,297
-824
-1% -$47.4K 0.08% 217
2014
Q3
$3.66M Sell
68,121
-1,269
-2% -$68.2K 0.07% 219
2014
Q2
$3.64M Sell
69,390
-104
-0.1% -$5.45K 0.07% 219
2014
Q1
$3.67M Sell
69,494
-9,704
-12% -$513K 0.07% 210
2013
Q4
$3.17M Buy
79,198
+10,164
+15% +$407K 0.06% 229
2013
Q3
$2.61M Sell
69,034
-83,498
-55% -$3.15M 0.05% 249
2013
Q2
$5.98M Buy
+152,532
New +$5.98M 0.13% 157